ERBB2 and neoplasm: Of the remaining 30 cases, 29 cases (96.7%) showed gene amplification and 1 tumor did not show erb2 gene amplification; this is likely to be a result of tumor heterogeneity for c-erb2 expression, which is a well-recognized phenomenon in gastric cancer.